PRE vs. ALNT, TRNS, LAB, CTKB, SENS, QSI, FEIM, MASS, QTRX, and RPID
Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Allient (ALNT), Transcat (TRNS), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), 908 Devices (MASS), Quanterix (QTRX), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry.
Prenetics Global vs. Its Competitors
Prenetics Global (NASDAQ:PRE) and Allient (NASDAQ:ALNT) are both small-cap measuring and control equipment companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.
Allient has a net margin of 2.75% compared to Prenetics Global's net margin of -87.92%. Allient's return on equity of 9.97% beat Prenetics Global's return on equity.
Prenetics Global pays an annual dividend of $2.80 per share and has a dividend yield of 20.0%. Allient pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Prenetics Global pays out -70.2% of its earnings in the form of a dividend. Allient pays out 14.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Prenetics Global is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Prenetics Global had 2 more articles in the media than Allient. MarketBeat recorded 8 mentions for Prenetics Global and 6 mentions for Allient. Prenetics Global's average media sentiment score of 0.67 beat Allient's score of 0.48 indicating that Prenetics Global is being referred to more favorably in the media.
Prenetics Global has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500. Comparatively, Allient has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500.
Allient has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.
25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 14.9% of Allient shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Prenetics Global currently has a consensus price target of $9.00, indicating a potential downside of 35.67%. Allient has a consensus price target of $35.00, indicating a potential downside of 32.39%. Given Allient's higher possible upside, analysts clearly believe Allient is more favorable than Prenetics Global.
Summary
Allient beats Prenetics Global on 11 of the 17 factors compared between the two stocks.
Get Prenetics Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prenetics Global Competitors List
Related Companies and Tools
This page (NASDAQ:PRE) was last updated on 10/14/2025 by MarketBeat.com Staff
